Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade Therapy

The emerging immune checkpoint blockade (ICB) therapy has ushered the cancer therapeutics field into an era of immunotherapy. Although ICB treatment provides remarkable clinical responses in a subset of patients with cancer, this regimen fails to extend survival in a large proportion of patients. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shuang, Zhou, Nianxin, Zhao, Linjie, Gimple, Ryan C., Ahn, Young Ha, Zhang, Peidong, Wang, Wei, Shao, Bin, Yang, Jingyun, Zhang, Qian, Zhao, Sai, Jiang, Xuehan, Chen, Zhiwei, Zeng, Yangfan, Hu, Hongbo, Gustafsson, Jan-Åke, Zhou, Shengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476860/
https://www.ncbi.nlm.nih.gov/pubmed/32861994
http://dx.doi.org/10.1016/j.isci.2020.101458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476860/
https://www.ncbi.nlm.nih.gov/pubmed/32861994
http://dx.doi.org/10.1016/j.isci.2020.101458

Ejemplares similares